Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.
作者信息
Mullighan Charles G, Jeha Sima, Pei Deqing, Payne-Turner Debbie, Coustan-Smith Elaine, Roberts Kathryn G, Waanders Esmé, Choi John K, Ma Xiaotu, Raimondi Susana C, Fan Yiping, Yang Wenjian, Song Guangchun, Yang Jun J, Inaba Hiroto, Downing James R, Leung Wing H, Bowman W Paul, Relling Mary V, Evans William E, Zhang Jinghui, Campana Dario, Pui Ching-Hon
机构信息
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
出版信息
Blood. 2015 Dec 24;126(26):2896-9. doi: 10.1182/blood-2015-09-671131. Epub 2015 Nov 2.
Abstract
摘要
相似文献
1
Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.基于微小残留病（MRD）水平的风险导向治疗对低二倍体急性淋巴细胞白血病儿童的疗效
Blood. 2015 Dec 24;126(26):2896-9. doi: 10.1182/blood-2015-09-671131. Epub 2015 Nov 2.
2
The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.全身照射方案对接受异基因造血干细胞移植的儿童和青年急性淋巴细胞白血病患者结局的影响。
Pediatr Blood Cancer. 2020 Feb;67(2):e28079. doi: 10.1002/pbc.28079. Epub 2019 Nov 14.
3
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment.监测高危复发性急性淋巴细胞白血病患儿的微小残留病：早期和晚期评估的预后相关性。
Leukemia. 2015 Aug;29(8):1648-55. doi: 10.1038/leu.2015.59. Epub 2015 Mar 9.
4
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy.适应性反应治疗的不同亚型急性淋巴细胞白血病患儿微小残留病的临床影响
Leukemia. 2017 Feb;31(2):333-339. doi: 10.1038/leu.2016.234. Epub 2016 Aug 18.
5
Cerebrospinal fluid analysis by 8-color flow cytometry in children with acute lymphoblastic leukemia.采用8色流式细胞术对急性淋巴细胞白血病患儿进行脑脊液分析。
Leuk Lymphoma. 2019 Nov;60(11):2825-2828. doi: 10.1080/10428194.2019.1602269. Epub 2019 Apr 25.
6
Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol.儿童急性淋巴细胞白血病移植前微小残留病的临床价值：法国微小残留病指导方案的结果。
Br J Haematol. 2014 May;165(3):392-401. doi: 10.1111/bjh.12749. Epub 2014 Jan 30.
7
Prognostic significance of flow cytometry MRD log reduction during induction treatment of childhood ALL.儿童急性淋巴细胞白血病诱导治疗期间流式细胞术微小残留病对数减少的预后意义
Leuk Lymphoma. 2019 Jan;60(1):258-261. doi: 10.1080/10428194.2018.1471603. Epub 2018 Jul 2.
8
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.微小残留病是复发的“高危”急性淋巴细胞白血病患儿预后的重要预测因素。
Leukemia. 2008 Dec;22(12):2193-200. doi: 10.1038/leu.2008.227. Epub 2008 Aug 28.
9
Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.复发/难治性B细胞急性淋巴细胞白血病患者中，微小残留病阴性根据挽救状态的差异影响。
Cancer. 2017 Jan 1;123(2):294-302. doi: 10.1002/cncr.30264. Epub 2016 Sep 7.
10
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse.儿童急性淋巴细胞白血病首次复发后微小残留病的临床意义
Leukemia. 2004 Mar;18(3):499-504. doi: 10.1038/sj.leu.2403283.
引用本文的文献
1
Insights into germline predisposition to pediatric lymphoid malignancies.对儿童淋巴系统恶性肿瘤种系易感性的见解。
Leukemia. 2025 Sep 9. doi: 10.1038/s41375-025-02750-z.
2
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.IKZF1基因改变的异质性与儿童B细胞前体急性淋巴细胞白血病的复发风险
Leukemia. 2025 May 13. doi: 10.1038/s41375-025-02633-3.
3
Application of Omics Analyses in Pediatric B-Cell Acute Lymphoblastic Leukemia.组学分析在儿童B细胞急性淋巴细胞白血病中的应用
Biomedicines. 2025 Feb 10;13(2):424. doi: 10.3390/biomedicines13020424.
4
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.IKZF1基因改变的异质性与儿童B细胞前体急性淋巴细胞白血病的复发风险
Res Sq. 2024 Nov 11:rs.3.rs-5292018. doi: 10.21203/rs.3.rs-5292018/v1.
5
The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemia.RNA 测序在诊断儿童 B 细胞急性淋巴细胞白血病患者对常规化疗不敏感的不明原因中的潜在作用。
BMC Med Genomics. 2024 May 29;17(1):149. doi: 10.1186/s12920-024-01892-w.
6
Measurable residual disease (MRD)-testing in haematological and solid cancers.血液系统和实体瘤中的可测量残留病灶（MRD）检测
Leukemia. 2024 Jun;38(6):1202-1212. doi: 10.1038/s41375-024-02252-4. Epub 2024 Apr 18.
7
Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia.儿童 B 细胞急性淋巴细胞白血病非整倍体概述。
Int J Mol Sci. 2023 May 15;24(10):8764. doi: 10.3390/ijms24108764.
8
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration.低倍体对儿科急性髓系白血病的生存有不良影响：国际血液和骨髓移植研究组的合作。
Blood Adv. 2023 Mar 28;7(6):1045-1055. doi: 10.1182/bloodadvances.2022008251.
9
Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children.超二倍体：已知的最长、最普遍、最神秘的儿童急性淋巴细胞白血病形式。
Leukemia. 2022 Dec;36(12):2769-2783. doi: 10.1038/s41375-022-01720-z. Epub 2022 Oct 20.
10
Hematopoietic stem cell transplantation from HLA-matched sibling donors in children with acute lymphoblastic leukemia: A report from the Children's Cancer Hospital Egypt.埃及儿童癌症医院报告：急性淋巴细胞白血病患儿接受来自人类白细胞抗原匹配同胞供者的造血干细胞移植情况
Front Oncol. 2022 Sep 27;12:983220. doi: 10.3389/fonc.2022.983220. eCollection 2022.
本文引用的文献
1
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.儿童急性淋巴细胞白血病：通过合作取得的进展
J Clin Oncol. 2015 Sep 20;33(27):2938-48. doi: 10.1200/JCO.2014.59.1636. Epub 2015 Aug 24.
2
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.儿童急性淋巴细胞白血病基于风险治疗背景下序贯微小残留病测量的临床效用：一项前瞻性研究
Lancet Oncol. 2015 Apr;16(4):465-74. doi: 10.1016/S1470-2045(15)70082-3. Epub 2015 Mar 20.
3
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.Ph 样急性淋巴细胞白血病中可靶向的激酶激活病变。
N Engl J Med. 2014 Sep 11;371(11):1005-15. doi: 10.1056/NEJMoa1403088.
4
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.根据微小残留病水平采用风险导向疗法治疗的BCR-ABL1样急性淋巴细胞白血病患儿的预后
J Clin Oncol. 2014 Sep 20;32(27):3012-20. doi: 10.1200/JCO.2014.55.4105.
5
Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.儿童和青少年费城染色体阴性的极高危急性淋巴细胞白血病：儿童肿瘤研究组AALL0031研究结果
Leukemia. 2014 Apr;28(4):964-7. doi: 10.1038/leu.2014.29. Epub 2014 Jan 17.
6
The genomic landscape of hypodiploid acute lymphoblastic leukemia.低倍体急性淋巴细胞白血病的基因组景观。
Nat Genet. 2013 Mar;45(3):242-52. doi: 10.1038/ng.2532. Epub 2013 Jan 20.
7
Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review.造血干细胞移植在儿童急性淋巴细胞白血病治疗中的细胞毒疗法作用：2005 年循证综述的更新。
Biol Blood Marrow Transplant. 2012 Apr;18(4):505-22. doi: 10.1016/j.bbmt.2011.12.585. Epub 2011 Dec 29.
8
Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia.缓解诱导治疗结束时微小残留病水平低对儿童急性淋巴细胞白血病的临床意义。
Blood. 2010 Jun 10;115(23):4657-63. doi: 10.1182/blood-2009-11-253435. Epub 2010 Mar 19.
9
Treating childhood acute lymphoblastic leukemia without cranial irradiation.不进行颅脑照射治疗儿童急性淋巴细胞白血病。
N Engl J Med. 2009 Jun 25;360(26):2730-41. doi: 10.1056/NEJMoa0900386.
10
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.IKZF1缺失与急性淋巴细胞白血病的预后
N Engl J Med. 2009 Jan 29;360(5):470-80. doi: 10.1056/NEJMoa0808253. Epub 2009 Jan 7.
Zotero 插件